Washington, DC – April 12, 2021 – Friends of Cancer Research would like to congratulate Dr. Patrizia Cavazzoni for being named the director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA).
“The naming of Dr. Cavazzoni as director of CDER at FDA by Acting Commissioner Woodcock and Secretary Becerra will assure FDA’s continued standing as the global gold standard for science and innovation,” said Ellen Sigal, Chair & Founder, Friends of Cancer Research. “She is a proven leader at the Agency and brings a deep breadth of experience in running complex clinical trials, drug development, and has shown her dedication to bettering the lives of patients.”
Friends of Cancer Research knows Dr. Cavazzoni will continue to execute innovative and crucial work for patients. We look forward to working with her in her new role at FDA.
About Friends of Cancer Research
Friends of Cancer Research (Friends) is working to accelerate policy change, support groundbreaking science, and deliver new therapies to patients quickly and safely. We unite scientists, pharmaceutical companies, and policy makers with shared trust and guide them toward meaningful cooperation. This collaboration among partners from every healthcare sector ultimately drives advances in science, policy, and regulation that speed life-saving treatments to patients. For more information, please visit www.friendsofcancerresearch.org/.
